#Santé #Recherche #Pharma #Tiques #Lyme BAXTER Disease Vaccine Shows Promise in Trial http://t.co/ZDNDBbFxc6 cc @ghabault
June 03, 2013
Publicité
Lyme Disease Vaccine Shows Promise in Trial
The results of a phase 1/2 clinical trial in Europe of an investigational Lyme disease vaccine co-developed by researchers at Stony Brook University, Brookhaven National Laboratory and at Baxter International Inc., a U.S. based healthcare company, revealed it to be promising and well tolerated, according to a research paper published online in The Lancet Infectious Diseases.